Current immunotherapies provide limited benefits against T cell-depleted tumors, calling for therapeutic innovation. Using multi-omics integration of cancer patient data, we predict a type I interferon (IFN) response HIGH state of dendritic cell (DC) vaccines, with efficacious clinical impact. However, preclinical DC vaccines recapitulating this state by combining immunogenic cancer cell death with induction of type I IFN responses fail to regress mouse tumors lacking T cell infiltrates. Here, in lymph nodes (LNs), instead of activating CD4 +/CD8 + T cells, DCs stimulate immunosuppressive programmed death-ligand 1-positive (PD-L1 +) LN-associated macrophages (LAMs). Moreover, DC vaccines also stimulate PD-L1 + tumor-associated macrophages (TAMs). This creates two anatomically distinct niches of PD-L1 + macrophages that suppress CD8 + T cells. Accordingly, a combination of PD-L1 blockade with DC vaccines achieves significant tumor regression by depleting PD-L1 + macrophages, suppressing myeloid inflammation, and de-inhibiting effector/stem-like memory T cells. Importantly, clinical DC vaccines also potentiate T cell-suppressive PD-L1 + TAMs in glioblastoma patients. We propose that a multimodal immunotherapy and vaccination regimen is mandatory to overcome T cell-depleted tumors.
Multi-omics analyses predict a highly immunogenic type I IFN HIGH DC vaccine state
DC vaccines fail because they facilitate PD-L1 + TAMs in lymph nodes and tumors
PD-L1 + TAMs suppress CD8 + T cell responses to disrupt DC vaccine efficacy
Targeting PD-L1 + TAMs via PD-L1 blockade improves DC vaccine-driven tumor control
Sprooten et al. use human-to-mouse reverse translation to create DC vaccines. Counterintuitively, these induce an accumulation of CD8 + T cell-suppressive PD-L1 + macrophages in lymph nodes and tumors, such that vaccination and co-blockade of PD-L1 (but not PD-1) is mandatory for tumor suppression. This pathway is also operational in DC vaccinated cancer patients.
See how this article has been cited at scite.ai
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.